No fetal mortality or morbidity occurred. The erythrocyte sedimentation rate is said to be elevated in most patients with Sweet's disease. The presence of anemia and low platelet count have been associated with an underlying malignancy. Earlier reports suggested an association of Sweet's disease with ANCA positivity, however further evaluation has cast doubt on this association. Management Systemic Corticosteroids Systemic corticosteroids have been the treatment of choice in most large series of patients reported.
Reduction is begun within two to four weeks.
Skin lesions should resolve within one to four weeks. They are occasionally used as solo therapy and can be effective in mild cases. It was first reported as useful in 1977. No recurrances were noted in a mean follow-up of 20 months. Indomethacin was then stopped.